MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 152 filers reported holding MANNKIND CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,544,751 | +15.6% | 2,068,947 | +13.9% | 1.57% | +22.2% |
Q2 2023 | $7,393,485 | +22.3% | 1,816,581 | +23.2% | 1.28% | -2.4% |
Q1 2023 | $6,043,802 | +11.2% | 1,474,098 | +43.0% | 1.31% | -9.2% |
Q4 2022 | $5,433,944 | +90.1% | 1,031,109 | +11.5% | 1.45% | +78.0% |
Q3 2022 | $2,858,000 | -1.9% | 924,979 | +20.9% | 0.81% | -24.2% |
Q2 2022 | $2,914,000 | +17.3% | 764,814 | +13.2% | 1.07% | +47.6% |
Q1 2022 | $2,485,000 | +113.9% | 675,403 | +154.0% | 0.73% | +184.0% |
Q4 2021 | $1,162,000 | +4.8% | 265,855 | +4.2% | 0.26% | -8.9% |
Q3 2021 | $1,109,000 | -74.7% | 255,047 | -68.3% | 0.28% | -70.7% |
Q2 2021 | $4,388,000 | +179.8% | 805,047 | +101.3% | 0.96% | +163.5% |
Q1 2021 | $1,568,000 | +137.6% | 400,000 | +13.9% | 0.36% | +108.0% |
Q3 2020 | $660,000 | -31.5% | 351,230 | -36.3% | 0.18% | -35.7% |
Q2 2020 | $964,000 | +3.9% | 551,117 | -38.8% | 0.27% | -36.7% |
Q1 2020 | $928,000 | -49.5% | 901,117 | -36.8% | 0.43% | -19.0% |
Q4 2019 | $1,839,000 | – | 1,425,302 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
1492 Capital Management LLC | 557,051 | $2,050,000 | 1.09% |
180 WEALTH ADVISORS, LLC | 1,369,904 | $4,877,000 | 1.06% |
EMERALD ADVISERS, LLC | 5,675,539 | $20,886,000 | 0.80% |
DG Capital Management, LLC | 1,035,693 | $3,811,000 | 0.76% |
Parkman Healthcare Partners LLC | 675,403 | $2,485,000 | 0.73% |
EMERALD MUTUAL FUND ADVISERS TRUST | 4,358,087 | $16,038,000 | 0.71% |
Avoro Capital Advisors LLC | 8,800,000 | $32,384,000 | 0.59% |
Monarch Partners Asset Management LLC | 420,478 | $1,547,000 | 0.35% |
Bruce & Co., Inc. | 395,073 | $1,453,000 | 0.30% |
SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,557,000 | 0.23% |